companies / laverocktx-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-08 json
| total_raised | 25,920,00025.9M | ○ |
|---|---|---|
| founded | 2021 | |
| hq | London, United Kingdom | |
| industry | unknown | |
| stage | seed |
Laverock Therapeutics develops programmable advanced therapies using RNA-based gene-control and cell-engineering platforms. It serves patients with unmet needs in oncology and beyond, plus partners across applications. Its disease-responsive systems fine-tune gene expression dynamically rather than using simple on/off switches.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-06-01 | seed | 25,164,00025.2M | null | ○ |
Cloudflare, LottieFiles 5.12.2, Google Font API, Google Hosted Libraries, Google Tag Manager, jquery 3.5.1
| fact | status | src |
|---|---|---|
| Seed, $25.2M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |